* Gross margins above its target of 80% * Order book at a record and foundation getting stronger * T...
* Q1e: 3% revenue decline y-o-y * '26e EBITDA toward bottom end of guidance range * Trading ~50% bel...
* Sales up 37% y-o-y as adj. EBITA more than doubled * Continued order momentum drives estimate upgr...
* Memory prices boost system sales in Q2-Q3e *Cost initiatives paying off simultaneously, adj.
Redeye comments on IRLAB's Q1 report and recently announced righs issue.
Redeye raises its forecast following surprisingly strong Q1’26 figures, with record volumes and EBIT...
Q1 NAV per share landed at € 35.29, down from € 36.
Westwing delivered its strongest quarterly growth since 2022, with GMV up 13% yoy to € 135m and reve...
Yesterday, DEMIRE published its Q1’26 results, coming in broadly in linw on both top-line and FFO.
Redeye provides an initial take following the release of Corline’s Q1 2026 report.
BeammWave's Q1 2026 print confirms continued progress towards commercialisation.
InfraCom's Q1 came in below Redeye's expectations. Net sales fell 3% y/y to SEK199m, missing Redeye'...
* Q1 EBIT of SEK -45m, vs. ABGSC of SEK +18m and cons.
Suominen’s operating environment remains quite challenging, but sales volumes and mix should be incr...
Catella's Q1 2026 print came in materially below both Redeye's below-consensus estimate and FactSet ...
* Q1: Organic growth of +7% despite tough comps (vs.
Redeye updates on EG7 after Q1-results where we expect strong performance in the remainder of the ye...
* Approval to initiate the financed TOTEMS study * Patient enrolment imminent Gabather has announce...
Redeye updates its estimates and valuation following Navigo releasing its Q1 2026 report.
OHB remains a compelling way to gain listed exposure to Europe’s sovereign space build-out.
GFT's Q1 26 came in bang in line with our expectations.
Raute’s low order book remains an issue for now, but in our view chances are European orders will be...
